Wedgewood's Acepromazine Maleate Injection Solution is a terminally sterilized, preserved multi-dose vial. It's formulated in a strength many companion animal veterinarians already dose to, without an in-clinic dilution step.
The HD label reflects Wedgewood's production facility designation, not the medication's hazard classification. Acepromazine is not classified as hazardous and is not a controlled substance. All handling guidance is included with the shipment of an order.
Acepromazine Maleate Injection Solution is compounded from the FDA-approved commercial product and available for office stock in states where allowed per state Boards of Pharmacy restrictions. This means that this medication can be sold to practices for office stock in all states except Hawaii, Montana, New York, Oregon, Rhode Island, South Dakota, and Washington D.C.
This medication is compounded from the FDA-approved commercial product at a lower strength of 1mg/ml.
The beyond-use date is 60 days from the date of compounding. We are pursuing stability studies to extend the BUD.